Skip to main content

Together we are beating cancer

Donate now
  • Policy & Insight

Cancer Research UK joins leading organisations in calling for Government to back R&D

by Amy Warnock | News

18 October 2024

0 comments 0 comments

scientists in a lab

We’ve joined the Campaign for Science and Engineering (CaSE), and other leading organisations in the Research and Development (R&D) sector, in writing to the Chancellor urging the UK Government to back R&D if it wants to achieve its ambitions for economic and social growth. 

We know the importance of R&D funding to achieving our vision of bringing about a world where everybody can lead longer, better lives, free from the fear of cancer. That’s why we highlighted it as one of our missions in our manifesto for cancer research and care. 

The UK life sciences sector is currently falling behind compared to its peers, but with a sustainable approach to biomedical research funding, the UK could become a top tier destination for clinical trials and attract industry investment.  

As well as scientific and patient benefits, R&D delivers significant benefits for the economy. If we maintain historic trends in cancer research investment, funding would top £3bn in 2040, supporting over 80,000 jobs and generating more than £13bn in economic benefits.  

But for these benefits to be realised, we need the UK Government to commit to continued investment in R&D. This will help to fuel economic growth, boost productivity, and enable scientists and innovators in cancer research to continue working to transform outcomes for people with cancer.  

“The Government highlights ‘the UK’s high quality research institutes and innovative firms’ as a key strength in the Industrial Strategy green paper published this week,” said Frances Downey, our head of science policy. “That strength only exists because of the UK’s world leading research and innovation base, which Cancer Research UK is proud to be a major investor in. It is in all of our interests, both for the economic prosperity of the UK and for the health of the nation, that we continue to invest and maintain that research and innovation base.” 

That’s why, with the Autumn budget fast approaching, we’re urging the Chancellor to consider the vital role that R&D will play in the Government’s long-term plans for growth.   

The Letter 

Dear Chancellor, 

It has been positive to hear the Government recognise the value of UK Research & Development (R&D) in growing the economy and tackling many of the big challenges facing society, including in the Industrial Strategy Green Paper published this week. 

What we have heard from Lord Vallance and the Secretary of State for Science, Innovation and Technology in recent weeks is cause for optimism about the future for UK research. It is exciting to see the direction R&D is headed in the planned spending review next year. However, it’s important that the Government doesn’t undermine the long-term ability of R&D to contribute to economic growth and improving public services through decisions made in the short term. 

This month’s budget is a critical moment. We recognise that there are difficult decisions to be made with the public finances, but it is vital that our long-term ability to grow the economy isn’t undermined by the false economy of short-term cuts. 

Reports of a re-profiling of investment leading to additional costs in DSIT’s 2025/26 budget, with no extra financing provided to cover a shortfall, are very concerning. It would mean deep cuts across other parts of R&D investment, with significant negative consequences for the UK’s world-leading R&D sector, putting the brakes on growth and undermining confidence. Cutting UK R&D now would be a false economy, the sector would lose stability, lose expertise, and lose momentum. 

We urge you to use the budget and spending review to commit to continued investment in R&D and signal, at home and abroad, that the UK is serious about R&D’s role in contributing to sustained economic growth. 

Doing so will fuel economic growth and boost productivity, enabling researchers and innovators to continue driving the high-skill sectors and cutting-edge technologies that will help shape the UK’s future. 

Crucially, certainty around stable public investment will also help leverage the private investment needed to achieve the Government’s ambitions for growth. 

Signatories 

Campaign for Science and Engineering (CaSE)
Association of Medical Research Charities
ARC (Advanced Research Clusters)
Babraham Institute
Biochemical Society
British Ecological Society
British Heart Foundation
Brunel University of London
Bruntwood SciTech
Cancer Research UK (CRUK)
Earlham Institute
Engineering Professors’ Council
Fraunhofer UK Research Limited
GW4
Institute of Acoustics
Institute of Physics (IOP)
John Innes Centre
LifeArc
London Mathematical Society (LMS)
London School of Hygiene and Tropical Medicine
Newcastle University
Quadram Institute
Royal Astronomical Society
Royal Society of Biology
Royal Society of Chemistry
Russell Group
The Association of the British Pharmaceutical Industry
The Geological Society
The Physiological Society
The Sainsbury Laboratory
UK Bioindustry Association (BIA)
UK Dementia Research Institute
Universities UK
University of Glasgow
University of Sussex
Wellcome
Wellcome Sanger Institute
Zoological Society of London (ZSL) 

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.